33rd AGM voting results: All 3 resolutions passed with near-unanimous support

Board & Shareholder Meetings View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.3%Reaction day

₹69.90

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+0.0% vs market

Pharmaceuticals peers, median of 173sector-0.8%-0.5% vs sector

On the reaction day the stock moved in line with Nifty Microcap 250 and 0.5 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.3-1.3+0.0-0.8-0.5

Next day

+2.1-1.3+3.4-1.3+3.3

-0.1+0.0-0.2-0.4+0.3

-1.4-0.2-1.2-0.1-1.3

-0.4-3.0+2.6-3.1+2.7

-2.6-2.7+0.1-3.1+0.5

-5.6-1.7-3.9-3.0-2.6

15d

-5.6-8.9+3.2-7.1+1.5

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Astal Laboratories held its 33rd AGM on Sept 29, 2026 via video conferencing. All 3 ordinary resolutions passed with overwhelming support: adoption of standalone financials (100% in favor), consolidated financials (100% in favor), and re-appointment of Mr. Maggidi Venkatesh as Non-Executive Director (99.9994% in favor). About 46.46% of total shares were polled.

Likely market impact

All resolutions passed smoothly with near-unanimous shareholder approval, indicating strong management support and no significant investor dissent.